Other Stories

Full Video

Moderna's COVID-19 vaccine makes twice more antibodies than Pfizer's according to Belgian study Updated: 2021-09-01 09:48:58 KST

According to a research done in Belgium Moderna's COVID-19 vaccine makes more than twice as many antibodies as Pfizer's.
The results were published on the Journal of American Medical Association website on Monday.
The study involved a group of 1,600 people whose blood samples were analyzed 6 to 10 weeks after their second doses.
Antibodies are known to be a key component of a human body's immune response, but the study didn't examine whether more antibodies meant a longer period of immunity before waning.
Both Moderna and Pfizer's mRNA vaccines have reported more than 90 percent effectiveness during the third phase of the clinical trials.
Reporter : tkim@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.